Top Funds / PERCEPTIVE ADVISORS LLC


Joseph Edelman

2018Q1 Portfolio

SEC 13F Filing

Position #Shares $Value % # vs. 2017Q4 $ vs. 2017Q4
NEUROCRINE BIOSCIENCES INC 4,761,989 $394,912,000 11.06% -389,600 -$4,800,000
AMICUS THERAPEUTICS, INC. 20,024,424 $301,167,000 8.44% +2,135,827 +$43,750,000
Global Blood Therapeutics, Inc. 4,989,066 $240,971,000 6.75% +100,000 +$48,587,000
ZOGENIX, INC. 3,970,357 $159,012,000 4.45% No Change -$1,787,000
ALNYLAM PHARMACEUTICALS, INC. 1,280,802 $152,543,000 4.27% -50,000 -$16,536,000
LA JOLLA PHARMACEUTICAL CO PAR $.0001 2 4,313,611 $128,459,000 3.60% +925,000 +$19,413,000
IOVANCE BIOTHERAPEUTICS, INC. 6,162,202 $104,141,000 2.92% +1,386,088 +$65,933,000
ALEXION PHARMACEUTICALS, INC. 873,450 $97,355,000 2.73% New +$97,355,000
ABIOMED INC 332,449 $96,739,000 2.71% +117,449 +$56,446,000
Blueprint Medicines Corp 1,030,434 $94,491,000 2.65% -110,000 +$8,491,000
DOVA PHARMACEUTICALS INC 2,780,977 $75,420,000 2.11% +971,962 +$23,321,000
CORIUM INTERNATIONAL INC 6,357,133 $72,916,000 2.04% +510,000 +$16,725,000
Retrophin, Inc. 3,212,871 $71,839,000 2.01% +540,346 +$15,529,000
Biohaven Pharmaceutical Holding Co Ltd. 2,927,449 $71,224,000 1.99% +2,666,315 +$64,179,000
Ascendis Pharma A/S SPONSORED ADR 982,647 $64,265,000 1.80% New +$64,265,000
CytomX Therapeutics, Inc. 2,208,812 $62,841,000 1.76% -281,569 +$10,270,000
Menlo Therapeutics Inc. 1,598,958 $60,089,000 1.68% New +$60,089,000
ACCELERON PHARMA INC 1,516,259 $59,286,000 1.66% -100,000 -$9,308,000
Alector, Inc. 1,704,330 $55,510,000 1.55% +384,330 +$21,718,000
DBV Technologies S.A. SPONSORED ADR 2,093,498 $48,296,000 1.35% New +$48,296,000
MERIT MEDICAL SYSTEMS INC 1,045,013 $47,391,000 1.33% +171,000 +$9,634,000
ARGENX SE 537,361 $43,225,000 1.21% New +$43,225,000
MyoKardia, Inc. 834,679 $40,732,000 1.14% +123,953 +$10,810,000
Xencor Inc 1,318,095 $39,516,000 1.11% +5,000 +$10,733,000
AVEXIS INC 276,400 $34,158,000 0.96% -203,741 -$18,979,000